The effect of galantamine on brain atrophy rate in subjects with mild cognitive impairment is modified by apolipoprotein E genotype: post-hoc analysis of data from a randomized controlled trial
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.